Tazobactam structure
|
Common Name | Tazobactam | ||
---|---|---|---|---|
CAS Number | 89786-04-9 | Molecular Weight | 300.291 | |
Density | 1.9±0.1 g/cm3 | Boiling Point | 707.1±70.0 °C at 760 mmHg | |
Molecular Formula | C10H12N4O5S | Melting Point | 172 °C(dec.) | |
MSDS | N/A | Flash Point | 381.4±35.7 °C |
Use of TazobactamTazobactam is a beta Lactamase Inhibitor with antibacterial activityTarget: AntibacterialTazobactam is a pharmaceutical drug that inhibits the action of bacterial β-lactamases, especially those belonging to the SHV-1 and TEM groups. It is commonly used as its sodium salt, Tazobactam sodium.Tazobactam is combined with the extended spectrum β-lactam antibiotic piperacillin in the drug piperacillin/Tazobactam, one of the preferred antibiotic treatments for nosocomial pneumonia caused by Pseudomonas aeruginosa. Tazobactam broadens the spectrum of piperacillin by making it effective against organisms that express β-lactamase and would normally degrade piperacillin. Tazobactam is derived from the penicillin nucleus and is a penicillinic acid sulfone. |
Name | tazobactam |
---|---|
Synonym | More Synonyms |
Description | Tazobactam is a beta Lactamase Inhibitor with antibacterial activityTarget: AntibacterialTazobactam is a pharmaceutical drug that inhibits the action of bacterial β-lactamases, especially those belonging to the SHV-1 and TEM groups. It is commonly used as its sodium salt, Tazobactam sodium.Tazobactam is combined with the extended spectrum β-lactam antibiotic piperacillin in the drug piperacillin/Tazobactam, one of the preferred antibiotic treatments for nosocomial pneumonia caused by Pseudomonas aeruginosa. Tazobactam broadens the spectrum of piperacillin by making it effective against organisms that express β-lactamase and would normally degrade piperacillin. Tazobactam is derived from the penicillin nucleus and is a penicillinic acid sulfone. |
---|---|
Related Catalog |
Density | 1.9±0.1 g/cm3 |
---|---|
Boiling Point | 707.1±70.0 °C at 760 mmHg |
Melting Point | 172 °C(dec.) |
Molecular Formula | C10H12N4O5S |
Molecular Weight | 300.291 |
Flash Point | 381.4±35.7 °C |
Exact Mass | 300.052826 |
PSA | 130.84000 |
LogP | -1.70 |
Vapour Pressure | 0.0±2.4 mmHg at 25°C |
Index of Refraction | 1.818 |
Storage condition | Store at?0-5°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Codes | Xi: Irritant; |
---|---|
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36/37/39-S45 |
RIDADR | UN 1770 8/PG 2 |
WGK Germany | 3 |
Packaging Group | II |
Hazard Class | 8 |
HS Code | 29036990 |
~% Tazobactam CAS#:89786-04-9 |
Literature: Synthesis, , # 3 art. no. F11904SS, p. 442 - 446 |
~% Tazobactam CAS#:89786-04-9 |
Literature: Synthesis, , # 3 art. no. F11904SS, p. 442 - 446 |
~% Tazobactam CAS#:89786-04-9 |
Literature: Synthesis, , # 3 art. no. F11904SS, p. 442 - 446 |
~% Tazobactam CAS#:89786-04-9 |
Literature: Synthesis, , # 3 art. no. F11904SS, p. 442 - 446 |
~% Tazobactam CAS#:89786-04-9 |
Literature: Synthesis, , # 3 art. no. F11904SS, p. 442 - 446 |
~% Tazobactam CAS#:89786-04-9 |
Literature: Synthesis, , # 3 art. no. F11904SS, p. 442 - 446 |
~% Tazobactam CAS#:89786-04-9 |
Literature: Synthesis, , # 3 art. no. F11904SS, p. 442 - 446 |
HS Code | 29036990 |
---|
MFCD00867002 |
YTR 830H |
Tazobactam |
[2S-(2a,3b,5a)]-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide |
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S,3S,5R)- |
T45 ANV ESWTJ F1 GVQ F1- AT5NNNJ &&(2S,3S,5R)- Form |
(2S,3S,5R)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide |
UNII-SE10G96M8W |
TAZOBACTANACID |
YTR-830H |
2b-[(1,2,3-triazol-1-yl)methyl]-2a-methylpenam-3a-carboxylic acid 1,1-dioxide |
Tazobactan acid |
2-METHANESULFONYL-5-(TRIFLUOROMETHYL)-1,3,4-THIADIAZOLE |